Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Health Policy (Amsterdam, Netherlands)|January 25, 2003
Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspectiveRichard Cookson, John Hutton
International Journal of Technology Assessment in Health Care|October 3, 2008
Harmonization of evidence requirements for health technology assessment in reimbursement decision makingJohn Hutton, Paul Trueman, Karen Facey
International Journal of Technology Assessment in Health Care|October 17, 2007
Coverage with evidence development: an examination of conceptual and policy issuesJohn Hutton, Paul Trueman, Christopher Henshall
International Journal of Technology Assessment in Health Care|May 8, 2012
A comparison of pharmaceutical reimbursement agencies' processes and methods in France and ScotlandMatthew Bending, John Hutton, Clare McGrath
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 5, 2002
Cost-effectiveness analysis of interferon beta in multiple sclerosis: a Markov process analysisMark J C Nuijten, John Hutton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 29, 2002
Development of a decision-analytic model of stroke care in the United States and EuropeMichael G Chambers, Peter Koch, John Hutton
International Journal of Technology Assessment in Health Care|October 23, 2009
The feasibility of harmonizing health technology assessments across jurisdictions: a case study of drug eluting stentsPaul Trueman, Manjusha Hurry, Matthew Bending, et al.
Pharmacoeconomics|November 29, 2002
Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?Rod S Taylor, John Hutton, Anthony J Culyer
Pageof 5